Literature DB >> 11181989

Migraine in Hughes syndrome--heparin as a therapeutic trial?

M J Cuadrado, M A Khamashta, D D'Cruz, G R Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11181989     DOI： 10.1093/qjmed/94.2.114

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  4 in total

Review 1.  Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome.

Authors:  G R V Hughes
Journal:  Postgrad Med J       Date:  2003-02       Impact factor: 2.401

Review 2.  Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).

Authors:  Maria J Cuadrado
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

3.  Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.

Authors:  Tomasz Hawro; Andrzej Bogucki; Maria Krupińska-Kun; Marcus Maurer; Anna Woźniacka
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

4.  Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis.

Authors:  Maria Mialdea; Shirish R Sangle; David P D'Cruz
Journal:  J Autoimmune Dis       Date:  2009-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.